These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 26592960)

  • 21. Resolution of Hydronephrosis in a Patient With Mucopolysaccharidosis Type II With Enzyme Replacement Therapy.
    Nishiyama K; Imai T; Ohkubo K; Sanefuji M; Takada H
    Urology; 2017 Mar; 101():163-165. PubMed ID: 28011272
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of idursulfase enzyme replacement therapy for Mucopolysaccharidosis type II when started in early infancy: comparison in two siblings.
    Tajima G; Sakura N; Kosuga M; Okuyama T; Kobayashi M
    Mol Genet Metab; 2013 Mar; 108(3):172-7. PubMed ID: 23375472
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Current and potential therapeutic strategies for mucopolysaccharidoses.
    Noh H; Lee JI
    J Clin Pharm Ther; 2014 Jun; 39(3):215-24. PubMed ID: 24612142
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Validation of Liquid Chromatography-Tandem Mass Spectrometry-Based 5-Plex Assay for Mucopolysaccharidoses.
    Oguni T; Tomatsu S; Tanaka M; Orii K; Fukao T; Watanabe J; Fukuda S; Notsu Y; Vu DC; Can TBN; Nagai A; Yamaguchi S; Taketani T; Gelb MH; Kobayashi H
    Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32188102
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of dipeptidyl peptidase-IV activity and/or structure homologs in human meningiomas.
    Stremenová J; Mares V; Lisá V; Hilser M; Krepela E; Vanicková Z; Syrucek M; Soula O; Sedo A
    Int J Oncol; 2010 Feb; 36(2):351-8. PubMed ID: 20043068
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of rapid cessation of enzyme replacement therapy: a report of 5 cases and a review of the literature.
    Jurecka A; Żuberuber Z; Opoka-Winiarska V; Węgrzyn G; Tylki-Szymańska A
    Mol Genet Metab; 2012 Nov; 107(3):508-12. PubMed ID: 22926198
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Enzyme replacement therapy: efficacy and limitations.
    Concolino D; Deodato F; Parini R
    Ital J Pediatr; 2018 Nov; 44(Suppl 2):120. PubMed ID: 30442189
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Biomarker responses correlate with antibody status in mucopolysaccharidosis type I patients on long-term enzyme replacement therapy.
    Langereis EJ; van Vlies N; Church HJ; Geskus RB; Hollak CE; Jones SA; Kulik W; van Lenthe H; Mercer J; Schreider L; Tylee KL; Wagemans T; Wijburg FA; Bigger BW
    Mol Genet Metab; 2015 Feb; 114(2):129-37. PubMed ID: 25467058
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vivo inhibition of dipeptidyl peptidase IV activity by pro-pro-diphenyl-phosphonate (Prodipine).
    De Meester I; Belyaev A; Lambeir AM; De Meyer GR; Van Osselaer N; Haemers A; Scharpé S
    Biochem Pharmacol; 1997 Jul; 54(1):173-9. PubMed ID: 9296364
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of siRNA-mediated silencing of glycosaminoglycan synthesis genes and enzyme replacement therapy for mucopolysaccharidosis in cell culture studies.
    Chmielarz I; Gabig-Cimińska M; Malinowska M; Banecka-Majkutewicz Z; Węgrzyn A; Jakobkiewicz-Banecka J
    Acta Biochim Pol; 2012; 59(4):697-702. PubMed ID: 23251908
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Changes in Corneal Clouding Over Time in Patients With Mucopolysaccharidosis.
    McGrath O; Sornalingam K; Aslam T; Ashworth J
    Cornea; 2023 Aug; 42(8):992-999. PubMed ID: 36857777
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Early initiation of enzyme replacement therapy for the mucopolysaccharidoses.
    Muenzer J
    Mol Genet Metab; 2014 Feb; 111(2):63-72. PubMed ID: 24388732
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intraindividual changes of dipeptidyl peptidase-IV in peripheral blood of patients with rheumatoid arthritis are associated with the disease activity.
    Sromova L; Busek P; Sedova L; Sedo A
    BMC Musculoskelet Disord; 2015 Sep; 16():244. PubMed ID: 26353808
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differential expression of dipeptidyl peptidase-IV (DPP-IV) in Indian type-2 diabetic population.
    Venkatesham A; Srinivas M; Krishna DR; Narayana P
    J Assoc Physicians India; 2009 Sep; 57():627-30. PubMed ID: 20213998
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Enzyme augmentation therapy enhances the therapeutic efficacy of bone marrow transplantation in mucopolysaccharidosis type II mice.
    Akiyama K; Shimada Y; Higuchi T; Ohtsu M; Nakauchi H; Kobayashi H; Fukuda T; Ida H; Eto Y; Crawford BE; Brown JR; Ohashi T
    Mol Genet Metab; 2014 Feb; 111(2):139-46. PubMed ID: 24100247
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Medical Costs Related to Enzyme Replacement Therapy for Mucopolysaccharidosis Types I, II, and VI in Brazil: A Multicenter Study.
    Bitencourt FH; Vieira TA; Steiner CE; Neto JC; Boy R; Schwartz IVD
    Value Health Reg Issues; 2015 Dec; 8():99-106. PubMed ID: 29698178
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serum dipeptidyl peptidase IV (DPP IV, CD26) activity in chronic hepatitis C.
    Firneisz G; Lakatos PL; Szalay F;
    Scand J Gastroenterol; 2001 Aug; 36(8):877-80. PubMed ID: 11495085
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Elevated serum dipeptidyl peptidase IV (CD26, EC 3.4.14.5) activity in experimental liver cirrhosis.
    Lakatos PL; Firneisz G; Borcsiczky D; Zalatnai A; Selmeci L; Szalay F
    Eur J Clin Invest; 2000 Sep; 30(9):793-7. PubMed ID: 10998079
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Preclinical dose ranging studies for enzyme replacement therapy with idursulfase in a knock-out mouse model of MPS II.
    Garcia AR; DaCosta JM; Pan J; Muenzer J; Lamsa JC
    Mol Genet Metab; 2007 Jun; 91(2):183-90. PubMed ID: 17459751
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficient analysis of urinary glycosaminoglycans by LC-MS/MS in mucopolysaccharidoses type I, II and VI.
    Auray-Blais C; Bhérer P; Gagnon R; Young SP; Zhang HH; An Y; Clarke JT; Millington DS
    Mol Genet Metab; 2011 Jan; 102(1):49-56. PubMed ID: 20934363
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.